Changes of Bone Turnover Markers and Bone Mineral Density After Osteoporosis Treatment

Shinshu University

Status and phase: Enrolling; Phase 4

Conditions: Osteoporosis

Treatments: Device: Ibandronic acid, vitamin D

Study type: Interventional

Funder types: Other

Identifiers

NCT02156999

IB2014

Details and patient eligibility

About

To examine the changes of bone mineral density and bone turnover markers after Bonviva treatment in osteoporotic patients

Enrollment: 100 estimated patients

Sex: All

Ages: 20 to 100 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Osteoporosis

Exclusion criteria

• Kidney, parathyroid, congenital bone metabolic disease

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

100 participants in 1 patient group

Osteoporosis

Experimental group

Treatment:

Device: Ibandronic acid, vitamin D